Echo IQ Company Description

Echo IQ Limited, an artificial intelligence (AI) and medical technology company, engages in the development and application of AI for the cardiac diagnostics sector in Australia.

It offers EchoSolv, a machine-learning and AI-based clinical decision support software for use as an adjunct to echocardiography in the assessment of severe aortic stenosis and other cardiovascular conditions.

The company has a research collaboration with Mayo Clinic to assess cardiac risk in patients receiving cancer therapy.

The company was formerly known as Houston We Have Limited and changed its name to EchoIQ Limited in December 2021.

Echo IQ Limited is headquartered in Sydney, Australia.

Echo IQ Limited

Country	Australia
Industry	Health Information Services
Sector	Healthcare
CEO	Dustin Haines

Contact Details

Address: 66 Clarence Street Sydney, NSW 2000 Australia
Phone	61 2 9159 3719
Website	echoiq.ai

Stock Details

Ticker Symbol	EIQ
Exchange	Australian Securities Exchange
Fiscal Year	July - June
Reporting Currency	AUD
ISIN Number	AU0000195430
SIC Code	7372

Key Executives

Name	Position
Dustin Haines	Chief Executive Officer
Andrew Richard Grover	Executive Chairman
Matthew Joseph Dodds III	Chief Financial Officer
Patrick O'Shea	Head of Strategy and Operations
Sam Dribin	Chief Technology Officer
Prof. David Playford	Chief Medical Advisor
Donald L. Fowler	President of Echo IQ USA
Deon Strydom	Chief Commercial Officer
Prof. Geoffrey A. Strange	Chief Research and Strategy Officer
Dane Brescacin	SVice President of Regulatory Affairs